Virax Biolabs Group Limited (VRAX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Virax Biolabs Group Limited  (NASDAQ: VRAX)

Virax Biolabs Group Limited Profitability Comparisons

Select each Category to receive further Information




VRAX Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) - 56.55 % 56.57 % 38.38 %
Gross Margin (Q1 TTM) - 56.4 % 52.62 % 37.3 %
Gross Profit Margin 5 Yr. Avg. - 59.21 % 54.71 % 32.75 %
EBITDA Margin (Q1 MRQ) - -50.27 % 15.98 % 24.08 %
EBITDA Margin (Q1 TTM) - 0.2 % 17.2 % 20.23 %
EBITDA Margin 5 Yr. Avg. - 17.14 % 30.23 % 22.75 %
Operating Margin (Q1 MRQ) - -61.81 % 8.6 % 15.5 %
Operating Margin (Q1 TTM) - -11.47 % 8.92 % 15 %
Operating Margin 5 Yr. Avg. - 7.81 % 14.36 % 15.96 %
Pre-Tax Profit Margin (Q1 MRQ) - -61.07 % 3.23 % 11.68 %
Pre-Tax Profit Margin (Q1 TTM) - -12.54 % 4.65 % 11.01 %
Pre-Tax Profit Margin 5 Yr. Avg. - 6.6 % 10.83 % 11.56 %
Net Margin (Q1 MRQ) - -60.84 % 1.71 % 9.31 %
Net Margin (Q1 TTM) - -14.92 % 5.24 % 9.14 %
Net Margin 5 Yr. Avg. - 2.64 % 6.81 % 9.04 %



Business Segment Profit Margin
 
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) - 4.42 % 0.88 % 0.71 %
Free Cash Flow Margin (Q1 TTM) - 1.2 % 11.71 % 9.59 %
Free Cash Flow Margin 5 Yr. Avg. - 7.83 % 17.59 % 16.03 %
Net Cash Flow Margin (Q1 MRQ) - 12.67 % -0.01 % 0.09 %
Net Cash Flow Margin (Q1 TTM) - 3.29 % -0.09 % 2.67 %
Net Cash Flow Margin 5 Yr. Avg. - 4.24 % 4.29 % 11.75 %
Effective Tax Rate (Q1 MRQ) - -0.23 % 48.94 % 20.85 %
Effective Tax Rate (Q1 TTM)